Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01698567 · ClinicalTrials.gov registry record · Phase 1
Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
A Phase 1 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01698567 is a Phase 1 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 6 participants.
The verdict
NCT01698567, a Phase 1 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to discern whether supplementation of Antithrombin III will decrease coagulation and inflammation associated with cardiopulmonary bypass in infants undergoing cardiac surgery.
Interventions
- DRUG Placebo
- DRUG Antithrombin III
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01698567
The ClinicalTrials.gov registry entry for NCT01698567 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01698567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01698567 about?
NCT01698567 is a clinical study titled "Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)". The purpose of this study is to discern whether supplementation of Antithrombin III will decrease coagulation and inflammation associated with cardiopulmonary bypass in infants undergoing cardiac surgery.
What is the current status of trial NCT01698567?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2012-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01698567?
The interventions under investigation include: Placebo (DRUG), Antithrombin III (DRUG).
Who is sponsoring clinical trial NCT01698567?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.